Oral immunotherapy for peanut allergy 'increases risk'
There is 'significant uncertainty' over the experimental treatment's long-term safety and efficacy, say experts
3rd May 2019
By Kemal Atlay
Oral immunotherapy for peanut allergy greatly increases the risk of life-threatening anaphylactic reactions rather than preventing them as intended, a review of trials has found.